News
Bayer hits "turning point" in recovery plan, says CEO
Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in Q3, says CEO Bill Anderson.
News
EVERSANA builds its AI Agency with Estima acquisition
EVERSANA has acquired UK AI-powered health economics and outcomes research (HEOR) firm Estima to help its customers "modernise commercialisation."
News
Merck charts course out of CDMO business with Lonza sale
Merck KGaA has moved to streamline its focus with the sale of its contract development and manufacturing organisation (CDMO) business to Lonza.
News
uniQure set for May FDA verdict on Huntington's gene therapy
The FDA has started its review of uniQure's gene therapy for neurodegenerative disorder Huntington's, but will require an advisory committee meeting.
Sales & Marketing
Sponsored
Solution Spotlight: BrandPRO Biopharma
Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
